Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
10.1245/s10434-008-9832-2
Annals of Surgical Oncology 15:1703-1709 (2008)
© 2008 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Gorechlad, J. W.
Right arrow Articles by Barth, R. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorechlad, J. W.
Right arrow Articles by Barth, R. J., Jr

Original Article

Screening for Recurrences in Patients Treated with Breast-Conserving Surgery: Is there a Role for MRI?

John W. Gorechlad, MD1, Elizabeth B. McCabe, MS, ARNP1, John H. Higgins, MS1, Donald S. Likosky, PhD1, Petra J. Lewis, MB, BS2, Kari M. Rosenkranz, MD1 and Richard J. Barth, Jr, MD1

1 Department of Surgery, Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH 03756, USA
2 Department of Radiology, Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH 03756, USA

Correspondence: Address correspondence and reprint requests to: Richard J. Barth Jr, MD; E-mail: Richard.J.Barth.Jr{at}Dartmouth.edu

Background: Although it has been shown that magnetic resonance imaging (MRI) is more sensitive than mammography in the detection of breast cancer in high-risk populations, there is little data on the use of MRI as a screening tool to detect recurrence after breast-conserving surgery. Our objective was to determine the potential role of MRI in the screening of breast cancer patients treated with breast-conserving surgery.

Methods: Retrospective chart review of all patients undergoing margin-negative lumpectomy and adjuvant radiation therapy for infiltrating breast carcinoma between 1st January 1993 and 1st January 2004. Patients were followed for recurrence in the ipsilateral or contralateral breast by physical exam and mammography.

Results: Four hundred and seventy-six primary tumor excisions were performed. Patients were followed for a median of 5.4 years. Ipsilateral breast recurrences developed in eight patients (1.7%) with a mean diameter of 1.6 cm. All of these women are alive and free of metastases. Contralateral cancers developed in 11 patients (2.3%) with a mean diameter of 1.5 cm. Ten of these 11 women are alive and free of disease.

Conclusions: In a contemporary patient population the risk of local recurrence after lumpectomy and radiation therapy is very low. If screening MRI had been a part of annual follow-up, a total of 2570 MRIs would have been performed. Given the small tumor size at detection and the excellent survival of those who recurred, annual screening MRI would have incurred significant cost and would have been unlikely to improve overall survival.

Key Words: Breast • Cancer • MRI • Screening • Recurrence






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society of Surgical Oncology.